spacer
home > pmps > summer 2008 > special dispensation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Special Dispensation

Pressure is increasing on today’s pharmaceutical industry to implement more reliable and consistent safeguards against mistakes in dispensing medication, whether from contamination, mixing up drugs or inappropriate dosing. As a result, pharmaceutical companies are turning to non-destructive testing (NDT) techniques for product and packaging inspection.

A number of these techniques have already been adopted, including the use of optical, infra-red, ultrasound, vacuum decay and x-ray inspection methods. Traditionally, these have primarily been used for batch control through various batch sampling and inspection strategies. However, there is increasing demand for in-line inspection of all products, particularly where they have high commercial value or involve high dosage levels.

Applications for in-line NDT of products are as varied as the products themselves. Typical inspection scenarios may entail: checking fill levels in bottles and tubs of drugs, in liquid, powder, and even tablet forms; checking for missing tablets in blister packs; detecting contaminants (such as metal or glass) in dressings; and checking for correctly assembled devices.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Martin Allen graduated from Nottingham University with an Honours Degree in Geology in 1989 and gained a Doctorate in Engineering in 1993, specialising in image processing and analysis. After two years of developing an advanced document imaging system, Martin joined the software department of OIS Engineering in 1996. Some 11 years later, OIS has become Shaw Inspection Systems, and Martin has become a leading expert in both digital radiography (DR), and computed tomography (CT). He now heads the software department and is responsible for current research and development into both DR and CT.
spacer
Martin Allen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Frost & Sullivan: The $700 Billion Connected Life Market that will Drive Change and Growth

LONDON - 26 March, 2015 - We are living a connected life in a connected world. Our smartphone is our gateway to the world and very soon we will be able to connect our glasses, watch, thermostat, lights, door locks and car. The connected life market has been valued by Frost & Sullivan at over $700 billion by 2020, but are companies prepared to drive and manage this change to stay ahead of the rapidly evolving world in which we live?
More info >>

White Papers

e-tools enhance clinical trial performance

e-novex

In today’s ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >>

 
Industry Events

Exploratory Clinical Development World Europe

2-3 June 2015, Bishopsgate, London, UK

Exploratory Clinical Development World Europe is recognised as the premier conference for understanding the right strategies and methods to assess safety & efficacy and make timely go/no go decisions.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement